Molecular Basis for Fungal Selectivity of Novel Antimitotic Compounds

AUTOR(ES)

Lila, Thomas

FONTE

American Society for Microbiology

RESUMO

Compounds that selectively disrupt fungal mitosis have proven to be effective in controlling agricultural pests, but no specific mitotic inhibitor is available for the treatment of systemic mycoses in mammalian hosts. In an effort to identify novel mitotic inhibitors, we used a cell-based screening strategy that exploited the hypersensitivity of a yeast α-tubulin mutant strain to growth inhibition by antimitotic agents. The compounds identified inhibited yeast nuclear division and included one structural class of compounds shown to be fungus specific. MC-305,904 and structural analogs inhibited fungal cell mitosis and inhibited the in vitro polymerization of fungal tubulin but did not block mammalian cell microtubule function or mammalian tubulin polymerization. Extensive analysis of yeast mutations that specifically alter sensitivity to MC-305,904 structural analogs suggested that compounds in the series bind to a site on fungal β-tubulin near amino acid 198. Features of the proposed binding site explain the observed fungal tubulin specificity of the series and are consistent with structure-activity relationships among a library of related compounds.

Documentos Relacionados

• Natural products as new antimitotic compounds for anticancer drug development
• Molecular Basis for the Selectivity of the Mammalian Bombesin Peptide, Neuromedin B, for Its Receptor
• Plant–pathogen microevolution: Molecular basis for the origin of a fungal disease in maize
• Structural basis for selectivity and toxicity of ribosomal antibiotics
• Molecular probes for diagnosis of fungal infections.